TwinStrand Biosciences nabs $50m Series B

TwinStrand Biosciences, a developer of duplex sequencing, has closed $50 million in Series B financing.

6 May 2021•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles